文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

富马酸盐和琥珀酸盐抑制依赖于 α-KG 的组蛋白和 DNA 去甲基酶,而这些物质在 FH 和 SDH 肿瘤抑制因子突变中积累。

Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.

机构信息

Molecular and Cell Biology Laboratory, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.

出版信息

Genes Dev. 2012 Jun 15;26(12):1326-38. doi: 10.1101/gad.191056.112. Epub 2012 Jun 7.


DOI:10.1101/gad.191056.112
PMID:22677546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3387660/
Abstract

Two Krebs cycle genes, fumarate hydratase (FH) and succinate dehydrogenase (SDH), are mutated in a subset of human cancers, leading to accumulation of their substrates, fumarate and succinate, respectively. Here we demonstrate that fumarate and succinate are competitive inhibitors of multiple α-ketoglutarate (α-KG)-dependent dioxygenases, including histone demethylases, prolyl hydroxylases, collagen prolyl-4-hydroxylases, and the TET (ten-eleven translocation) family of 5-methlycytosine (5mC) hydroxylases. Knockdown of FH and SDH results in elevated intracellular levels of fumarate and succinate, respectively, which act as competitors of α-KG to broadly inhibit the activity of α-KG-dependent dioxygenases. In addition, ectopic expression of tumor-derived FH and SDH mutants inhibits histone demethylation and hydroxylation of 5mC. Our study suggests that tumor-derived FH and SDH mutations accumulate fumarate and succinate, leading to enzymatic inhibition of multiple α-KG-dependent dioxygenases and consequent alterations of genome-wide histone and DNA methylation. These epigenetic alterations associated with mutations of FH and SDH likely contribute to tumorigenesis.

摘要

两个克雷布斯循环基因,延胡索酸水合酶(FH)和琥珀酸脱氢酶(SDH),在人类癌症的一个亚群中发生突变,导致它们的底物延胡索酸和琥珀酸分别积累。在这里,我们证明了延胡索酸和琥珀酸分别是多种α-酮戊二酸(α-KG)依赖性加双氧酶的竞争性抑制剂,包括组蛋白去甲基酶、脯氨酰羟化酶、胶原蛋白脯氨酰-4-羟化酶和 TET(十-十一易位)家族的 5-甲基胞嘧啶(5mC)羟化酶。FH 和 SDH 的敲低分别导致细胞内延胡索酸和琥珀酸水平升高,它们作为 α-KG 的竞争物广泛抑制 α-KG 依赖性加双氧酶的活性。此外,肿瘤衍生的 FH 和 SDH 突变体的异位表达抑制组蛋白去甲基化和 5mC 的羟化。我们的研究表明,肿瘤衍生的 FH 和 SDH 突变积累延胡索酸和琥珀酸,导致多种 α-KG 依赖性加双氧酶的酶抑制,并导致全基因组组蛋白和 DNA 甲基化的改变。与 FH 和 SDH 突变相关的这些表观遗传改变可能有助于肿瘤发生。

相似文献

[1]
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.

Genes Dev. 2012-6-7

[2]
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.

Oncotarget. 2015-11-17

[3]
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

Cancer Cell. 2011-1-18

[4]
The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.

Lab Invest. 2018-1-16

[5]
Exposure to high levels of fumarate and succinate leads to apoptotic cytotoxicity and altered global DNA methylation profiles in vitro.

Biochimie. 2017-4

[6]
Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells.

Mol Cell Biol. 2007-5

[7]
Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.

Oncotarget. 2022

[8]
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.

Hum Mol Genet. 2005-8-1

[9]
Oxygen concentration controls epigenetic effects in models of familial paraganglioma.

PLoS One. 2015-5-18

[10]
Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma.

Hum Mol Genet. 2007-12-15

引用本文的文献

[1]
TCA cycle-derived oncometabolites in cancer and the immune microenvironment.

J Biomed Sci. 2025-9-10

[2]
α-Ketoglutarate dictates AMPK protein synthesis for energy sensing in human cancers.

Nat Chem Biol. 2025-8-22

[3]
Deciphering the Molecular Dialogue: Mitochondria, Epigenetics, and Extracellular Vesicles in Placental Function and Pregnancy Complications.

Compr Physiol. 2025-8

[4]
Nuclear functional role of metabolic enzymes and related metabolites: Focus on gene expression regulation.

Mol Metab. 2025-8-7

[5]
Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinoma.

Clin Exp Metastasis. 2025-8-8

[6]
Distinct proteomic and acylproteomic adaptations to succinate dehydrogenase loss in two cell contexts.

bioRxiv. 2025-8-2

[7]
Mitochondrial dysfunction-mediated metabolic remodeling of TCA cycle promotes Parkinson's disease through inhibition of H3K4me3 demethylation.

Cell Death Discov. 2025-7-29

[8]
Inhibition of HDAC6 alters fumarate hydratase activity and mitochondrial structure.

Nat Commun. 2025-7-28

[9]
KDM6A downregulation promotes tumor-prone cytokines expression in cancer-associated fibroblasts by activating enhancers.

Cell Death Dis. 2025-7-14

[10]
and investigations provide insights into maleidride biosynthesis in fungi.

RSC Adv. 2025-7-4

本文引用的文献

[1]
Alterations of metabolic genes and metabolites in cancer.

Semin Cell Dev Biol. 2012-1-28

[2]
IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.

Histopathology. 2012-1

[3]
Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.

Cancer Cell. 2011-10-18

[4]
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma.

Cancer Cell. 2011-10-18

[5]
Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA.

Science. 2011-8-4

[6]
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine.

Science. 2011-7-21

[7]
SDH mutations in cancer.

Biochim Biophys Acta. 2011-11

[8]
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.

J Pathol. 2011-5-19

[9]
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.

EMBO Rep. 2011-4-1

[10]
Inhibition of 2-oxoglutarate dependent oxygenases.

Chem Soc Rev. 2011-3-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索